BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 9554430)

  • 1. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia.
    Lim KO; Adalsteinsson E; Spielman D; Sullivan EV; Rosenbloom MJ; Pfefferbaum A
    Arch Gen Psychiatry; 1998 Apr; 55(4):346-52. PubMed ID: 9554430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation.
    Auer DP; Wilke M; Grabner A; Heidenreich JO; Bronisch T; Wetter TC
    Schizophr Res; 2001 Oct; 52(1-2):87-99. PubMed ID: 11595395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study.
    Sigmundsson T; Maier M; Toone BK; Williams SC; Simmons A; Greenwood K; Ron MA
    Schizophr Res; 2003 Nov; 64(1):63-71. PubMed ID: 14511802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging.
    Bertolino A; Kumra S; Callicott JH; Mattay VS; Lestz RM; Jacobsen L; Barnett IS; Duyn JH; Frank JA; Rapoport JL; Weinberger DR
    Am J Psychiatry; 1998 Oct; 155(10):1376-83. PubMed ID: 9766769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
    MacKay S; Meyerhoff DJ; Constans JM; Norman D; Fein G; Weiner MW
    Arch Neurol; 1996 Feb; 53(2):167-74. PubMed ID: 8639067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gray and white matter brain chemistry in young children with autism.
    Friedman SD; Shaw DW; Artru AA; Dawson G; Petropoulos H; Dager SR
    Arch Gen Psychiatry; 2006 Jul; 63(7):786-94. PubMed ID: 16818868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton magnetic resonance spectroscopy of the human brain in schizophrenia.
    Deicken RF; Johnson C; Pegues M
    Rev Neurosci; 2000; 11(2-3):147-58. PubMed ID: 10718151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short echo time multislice proton magnetic resonance spectroscopic imaging in human brain: metabolite distributions and reliability.
    Wiedermann D; Schuff N; Matson GB; Soher BJ; Du AT; Maudsley AA; Weiner MW
    Magn Reson Imaging; 2001 Oct; 19(8):1073-80. PubMed ID: 11711231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylaspartate reductions in the mediodorsal and anterior thalamus in men with schizophrenia verified by tissue volume corrected proton MRSI.
    Jakary A; Vinogradov S; Feiwell R; Deicken RF
    Schizophr Res; 2005 Jul; 76(2-3):173-85. PubMed ID: 15949650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging.
    Bertolino A; Nawroz S; Mattay VS; Barnett AS; Duyn JH; Moonen CT; Frank JA; Tedeschi G; Weinberger DR
    Am J Psychiatry; 1996 Dec; 153(12):1554-63. PubMed ID: 8942451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton spectroscopy of human brain: effects of age and sex.
    Charles HC; Lazeyras F; Krishnan KR; Boyko OB; Patterson LJ; Doraiswamy PM; McDonald WM
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Oct; 18(6):995-1004. PubMed ID: 7824764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
    Meyerhoff DJ; MacKay S; Constans JM; Norman D; Van Dyke C; Fein G; Weiner MW
    Ann Neurol; 1994 Jul; 36(1):40-7. PubMed ID: 8024260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia.
    Deicken RF; Zhou L; Schuff N; Weiner MW
    Schizophr Res; 1997 Oct; 27(1):65-71. PubMed ID: 9373896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamatergic and Neuronal Dysfunction in Gray and White Matter: A Spectroscopic Imaging Study in a Large Schizophrenia Sample.
    Bustillo JR; Jones T; Chen H; Lemke N; Abbott C; Qualls C; Stromberg S; Canive J; Gasparovic C
    Schizophr Bull; 2017 May; 43(3):611-619. PubMed ID: 27550776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging.
    Schuff N; Ezekiel F; Gamst AC; Amend DL; Capizzano AA; Maudsley AA; Weiner MW
    Magn Reson Med; 2001 May; 45(5):899-907. PubMed ID: 11323817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-brain proton MR spectroscopic imaging in Parkinson's disease.
    Levin BE; Katzen HL; Maudsley A; Post J; Myerson C; Govind V; Nahab F; Scanlon B; Mittel A
    J Neuroimaging; 2014; 24(1):39-44. PubMed ID: 23228009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analytic evidence of elevated choline, reduced N-acetylaspartate, and normal creatine in schizophrenia and their moderation by measurement quality, echo time, and medication status.
    Yang YS; Smucny J; Zhang H; Maddock RJ
    Neuroimage Clin; 2023; 39():103461. PubMed ID: 37406595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative metabolite concentrations and ratios determined by use of 3-T region-specific proton magnetic resonance spectroscopy of the brain of healthy Beagles.
    Warrington CD; Feeney DA; Ober CP; Jessen CR; Steward SM; Armién AG; Fletcher TF
    Am J Vet Res; 2013 Oct; 74(10):1291-303. PubMed ID: 24066913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.